Longevity supplements firm eyes pet longevity

Rejuvant founder in talks with US pet food manufacturers as company seeks to bring the benefits of alpha ketoglutarate to companion animals.

Human longevity supplement developer Rejuvant is preparing to move into clinical studies in dogs, as the company eyes the pet longevity market. Rejuvant’s CEO says the company is in advanced talks with a specialty pet food manufacturer about potentially including the company’s patent-pending longevity ingredient, LifeAKG, in pet food products.

My take on this: That Rejuvant is now looking to expand its successful human supplement business into the world of pet longevity is an interesting move, with companies like Loyal demonstrating that extending the healthspan and lifespan of our animal companions is a cause worth pursuing. We caught up with Rejuvant founder and CEO Thomas Weldon to learn more.

The molecule calcium alpha-ketoglutarate (CaAKG) lies at the core of all Rejuvant’s supplements. Studies have shown CaAKG may be effective in treating osteoporosis, preventing a decline in protein synthesis, reducing frailty, and even compressing morbidity. Last year, a randomized retrospective study of 42 individuals showed the supplement reduced biological age by an average of eight years after taking the dietary supplement for seven months.

Delve deeper on topics like pet longevity, potential dog food partnership and biological age testing HERE.

Thank you for reading! If you enjoyed this article, it would mean a lot to me if you could subscribe and share it on LinkedIn!